These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28520515)
1. Overcoming the tumor microenvironment: the role of nanohyperthermia. Silva AK; Nicolas-Boluda A; Fouassier L; Gazeau F Nanomedicine (Lond); 2017 Jun; 12(11):1213-1215. PubMed ID: 28520515 [No Abstract] [Full Text] [Related]
2. Physical oncology: New targets for nanomedicine. Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739 [TBL] [Abstract][Full Text] [Related]
3. Clinical applications of magnetic nanoparticles for hyperthermia. Thiesen B; Jordan A Int J Hyperthermia; 2008 Sep; 24(6):467-74. PubMed ID: 18608593 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
5. Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Campbell RB Nanomedicine (Lond); 2007 Oct; 2(5):649-52. PubMed ID: 17976026 [No Abstract] [Full Text] [Related]
6. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Overchuk M; Zheng G Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323 [TBL] [Abstract][Full Text] [Related]
8. Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine. Yoshii T; Geng Y; Peyton S; Mercurio AM; Rotello VM Drug Discov Today; 2016 Sep; 21(9):1489-1494. PubMed ID: 27238384 [TBL] [Abstract][Full Text] [Related]
9. An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer. Karponis D; Azzawi M; Seifalian A Nanomedicine (Lond); 2016 Aug; 11(16):2215-32. PubMed ID: 27480599 [TBL] [Abstract][Full Text] [Related]
10. Reprogramming Tumor Microenvironment with Photothermal Therapy. Hu Q; Huang Z; Duan Y; Fu Z; Bin Liu Bioconjug Chem; 2020 May; 31(5):1268-1278. PubMed ID: 32271563 [TBL] [Abstract][Full Text] [Related]
11. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy. Curtis LT; Frieboes HB Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048 [TBL] [Abstract][Full Text] [Related]
13. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? Danhier F J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992 [TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticles in cancer therapy: how can thermal approaches help? Kolosnjaj-Tabi J; Wilhelm C Nanomedicine (Lond); 2017 Mar; 12(6):573-575. PubMed ID: 28244818 [No Abstract] [Full Text] [Related]
16. The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer. Majeski HE; Yang J Mol Pharmacol; 2016 Dec; 90(6):744-754. PubMed ID: 27742780 [TBL] [Abstract][Full Text] [Related]
17. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors. Frazier N; Ghandehari H Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079 [TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity by magnetic nanoparticle-mediated hyperthermia. Kobayashi T; Kakimi K; Nakayama E; Jimbow K Nanomedicine (Lond); 2014 Aug; 9(11):1715-26. PubMed ID: 25321171 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for thermal cancer therapy. Day ES; Morton JG; West JL J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133 [TBL] [Abstract][Full Text] [Related]
20. Nanomedicine as a potent strategy in melanoma tumor microenvironment. Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]